Decreased IL-37 expression in hepatocellular carcinoma tissues and liver cancer cell lines.
IL-37
NF-κB
hepatocellular carcinoma
paracancerous tissues
α-fetoprotein
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
21
06
2019
accepted:
16
10
2019
entrez:
29
3
2020
pubmed:
29
3
2020
medline:
29
3
2020
Statut:
ppublish
Résumé
The role of IL-37 in cancer is currently largely unknown. The present study aimed to investigate IL-37 expression in hepatocellular carcinoma (HCC), paracancerous tissues (PT) and liver cancer cell lines, and their associations between IL-37 and NF-κB. A total of 65 HCC and 65 PT tissues were collected. The expression of IL-37 and NF-κB in tissues was detected by immunohistochemistry (IHC) and the data was analyzed using SPSS software. In the
Identifiants
pubmed: 32218814
doi: 10.3892/ol.2020.11393
pii: OL-0-0-11393
pmc: PMC7068331
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2639-2648Informations de copyright
Copyright: © Li et al.
Références
Clin Gastroenterol Hepatol. 2018 May;16(5):765-773.e2
pubmed: 29246694
Exp Ther Med. 2012 Oct;4(4):655-660
pubmed: 23170121
Transl Oncol. 2018 Oct;11(5):1202-1212
pubmed: 30075461
J Exp Clin Cancer Res. 2016 Jan 20;35:13
pubmed: 26791086
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8179-8185
pubmed: 30556856
J Transl Med. 2014 Mar 16;12:69
pubmed: 24629023
Cytokine. 2018 Jun;106:89-94
pubmed: 29111085
Nat Immunol. 2012 Oct;13(10):925-31
pubmed: 22990890
J Gastroenterol Hepatol. 2016 Jul;31(7):1300-6
pubmed: 26751608
Kidney Int. 2015 Feb;87(2):396-408
pubmed: 25207880
Nat Rev Immunol. 2018 May;18(5):309-324
pubmed: 29379212
Oncotarget. 2017 Jul 25;8(30):49064-49075
pubmed: 28467774
Arch Gynecol Obstet. 2018 Jun;297(6):1525-1532
pubmed: 29610946
Int Immunopharmacol. 2019 Apr;69:27-33
pubmed: 30665041
Cytokine. 2018 Oct;110:291-297
pubmed: 29500054
Cancer Immunol Res. 2014 Sep;2(9):823-30
pubmed: 25187272
Onco Targets Ther. 2019 Apr 10;12:2703-2712
pubmed: 31114224
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2019 Feb;36(2):320-326
pubmed: 30696374
Int Immunopharmacol. 2019 Apr;69:184-193
pubmed: 30735937
ScientificWorldJournal. 2011;11:2480-90
pubmed: 22235179
J Cancer. 2015 Aug 08;6(10):962-9
pubmed: 26316892
Thorac Cancer. 2018 May;9(5):621-629
pubmed: 29575809
Sci Rep. 2014 Jun 05;4:5177
pubmed: 24898887
Sci Rep. 2017 Mar 31;7:45846
pubmed: 28361988
J Immunol. 2016 Jul 15;197(2):630-43
pubmed: 27288535
Clin Gastroenterol Hepatol. 2016 Apr;14(4):597-605
pubmed: 26707683
Anal Chem. 2017 Sep 5;89(17):8877-8883
pubmed: 28770990
Acta Pharmacol Sin. 2015 Nov;36(11):1377-87
pubmed: 26190499